Skip to main content
FRNM $10.61 -8.22%
FRNM · Freenome, Inc.
Track FRNM — free
$10.61 -0.95 (-8.22%) At close · Nov 12
Market Cap
$109.43M
Shares
10.31M
Volume · Nov 12 904.31K Avg daily vol (3M) 861.18K
All webcasts

Earnings call · FY2026 Q3

Freenome, Inc. (FRNM) Q3 2026 Earnings Call

Concluded Nov 10, 2026
Nov 10, 2026
Period
FY2026 Q3
Runtime
—
Sources
2 artifacts
Revenue $183.49M +17628.4% YoY
Diluted EPS $0.58
Gross margin · derived Q4 99.7% +58.7 pp YoY
Net income $60.11M
Open full screen 8-K 10-Q

Executive readout · one minute

What the filings say

10-Q report · filed Nov 12, 2026
Freenome reported $182.5 million of third-quarter collaboration revenue and quarterly net income after SimpleScreen CRC received FDA approval, triggering $180.0 million of revenue recognition. The nine-month net loss was $72.5 million.

The audio replay and transcript follow the call.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

License and Collaboration$182.55M
Service and Other$942,000 -9% YoY
Early CDT Lung Royalties$500,000 +66.7% YoY
Early CDT Lung Test Kits$300,000 +0% YoY
Early CDT Lung Test Plates$100,000 +0% YoY
Diagnostic and Research Services$0 -100% YoY
Full-screen source Call document